InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Meltz Mark A. Insider active across 1 company, notably Kinnate Biopharma Inc.. Aggregated, 8 filings have been logged. History available since 1 September 2022. The latest transaction was disclosed on 1 March 2024 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Meltz Mark A is a declarant linked to Kinnate Biopharma Inc. (XNAS), where the listed role is COO GENERAL COUNSEL SECRETARY. He has 8 filings in total, and the sampled recent filings cover the period from 2022-09-02 to 2024-04-05, with Retenue fiscale as the most frequent transaction nature and individual amounts up to EUR 4021.685884761866.